XML 68 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Contingencies - Additional Information (Detail)
€ in Millions
 1 Months Ended 6 Months Ended 12 Months Ended
Jul. 21, 2021
USD ($)
Nov. 20, 2020
EUR (€)
Oct. 21, 2019
USD ($)
Aug. 21, 2017
USD ($)
Jul. 15, 2015
USD ($)
May 31, 2019
USD ($)
Aug. 31, 2012
USD ($)
Dec. 31, 2010
USD ($)
Aug. 31, 2008
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2014
USD ($)
Jul. 08, 2021
USD ($)
Sep. 01, 2020
USD ($)
Jan. 31, 2009
USD ($)
Jul. 31, 2008
USD ($)
Feb. 28, 2005
USD ($)
Commitment And Contingencies [Line Items]                                  
Damages assessment                   $ 235,500,000              
Annual sales at the time of settlement                           $ 700,000,000 $ 350,000,000    
Annual sales of Effexor       $ 2,600,000,000                          
Annual sales of Lamictal                               $ 2,300,000,000 $ 950,000,000
Annual sales of Aggrenox         $ 1,100,000       $ 416,000,000                
Annual sales of Actos             $ 2,800,000,000 $ 3,700,000,000                  
Annual sales of Acto plus             $ 430,000,000 $ 500,000,000                  
Annual Sales Of Sensipar                     $ 1,400,000,000            
Annual Sales Of Copaxone                       $ 380,000,000          
Fines Imposed In Period | €   € 60.5                              
Loss contingency, claims dismissed, value                   925,000              
Accrual for environmental loss contingencies                   300,000              
Loss contingencies on environmental laws, penalty                         $ 1,400,000        
Opioid Litigation [Member]                                  
Commitment And Contingencies [Line Items]                                  
Litigation settlement amount     $ 25,000,000     $ 85,000,000                      
Litigation settlement amount awarded distribution period     3 years                            
Litigation settlement amount awarded cash amount     $ 20,000,000                            
Nationwide Settlement [Member]                                  
Commitment And Contingencies [Line Items]                                  
Litigation settlement amount     $ 23,000,000,000                            
Litigation settlement amount awarded distribution period     10 years                            
Litigation settlement amount awarded cash amount     $ 250,000,000                            
Litigation settlement amount awarded cash amount distribution period     10 years                            
Nationwide Settlement [Member] | Subsequent Event [Member] | Four Other Defendants Other Than Teva [Member]                                  
Commitment And Contingencies [Line Items]                                  
Loss contingency payment $ 26,000,000,000                                
Litigation settlement amount awarded distribution period 18 years                                
Eosinophilic Esophagitis [Member]                                  
Commitment And Contingencies [Line Items]                                  
Damage claimed                   200,000,000              
Eosinophilic Esophagitis [Member] | United States [Member]                                  
Commitment And Contingencies [Line Items]                                  
Damage claimed                   150,000,000              
Eosinophilic Esophagitis [Member] | Europe [Member]                                  
Commitment And Contingencies [Line Items]                                  
Damage claimed                   $ 50,000,000              
AndroGel Rate at 1% [Member]                                  
Commitment And Contingencies [Line Items]                                  
Annual sales at the time of settlement                             $ 140,000,000